QQQ   418.07 (-1.26%)
AAPL   165.13 (-1.14%)
MSFT   401.05 (-0.80%)
META   485.91 (-3.17%)
GOOGL   154.54 (-0.94%)
AMZN   175.54 (-2.05%)
TSLA   148.64 (-0.86%)
NVDA   796.73 (-5.90%)
AMD   149.37 (-3.68%)
NIO   3.83 (-4.25%)
BABA   68.96 (+0.12%)
T   16.41 (+0.49%)
F   12.13 (+0.58%)
MU   107.36 (-4.08%)
GE   149.59 (-2.19%)
CGC   8.12 (+3.70%)
DIS   112.30 (-0.12%)
AMC   3.23 (+10.62%)
PFE   25.83 (+1.73%)
PYPL   62.18 (+0.13%)
XOM   119.99 (+1.24%)
QQQ   418.07 (-1.26%)
AAPL   165.13 (-1.14%)
MSFT   401.05 (-0.80%)
META   485.91 (-3.17%)
GOOGL   154.54 (-0.94%)
AMZN   175.54 (-2.05%)
TSLA   148.64 (-0.86%)
NVDA   796.73 (-5.90%)
AMD   149.37 (-3.68%)
NIO   3.83 (-4.25%)
BABA   68.96 (+0.12%)
T   16.41 (+0.49%)
F   12.13 (+0.58%)
MU   107.36 (-4.08%)
GE   149.59 (-2.19%)
CGC   8.12 (+3.70%)
DIS   112.30 (-0.12%)
AMC   3.23 (+10.62%)
PFE   25.83 (+1.73%)
PYPL   62.18 (+0.13%)
XOM   119.99 (+1.24%)
QQQ   418.07 (-1.26%)
AAPL   165.13 (-1.14%)
MSFT   401.05 (-0.80%)
META   485.91 (-3.17%)
GOOGL   154.54 (-0.94%)
AMZN   175.54 (-2.05%)
TSLA   148.64 (-0.86%)
NVDA   796.73 (-5.90%)
AMD   149.37 (-3.68%)
NIO   3.83 (-4.25%)
BABA   68.96 (+0.12%)
T   16.41 (+0.49%)
F   12.13 (+0.58%)
MU   107.36 (-4.08%)
GE   149.59 (-2.19%)
CGC   8.12 (+3.70%)
DIS   112.30 (-0.12%)
AMC   3.23 (+10.62%)
PFE   25.83 (+1.73%)
PYPL   62.18 (+0.13%)
XOM   119.99 (+1.24%)
QQQ   418.07 (-1.26%)
AAPL   165.13 (-1.14%)
MSFT   401.05 (-0.80%)
META   485.91 (-3.17%)
GOOGL   154.54 (-0.94%)
AMZN   175.54 (-2.05%)
TSLA   148.64 (-0.86%)
NVDA   796.73 (-5.90%)
AMD   149.37 (-3.68%)
NIO   3.83 (-4.25%)
BABA   68.96 (+0.12%)
T   16.41 (+0.49%)
F   12.13 (+0.58%)
MU   107.36 (-4.08%)
GE   149.59 (-2.19%)
CGC   8.12 (+3.70%)
DIS   112.30 (-0.12%)
AMC   3.23 (+10.62%)
PFE   25.83 (+1.73%)
PYPL   62.18 (+0.13%)
XOM   119.99 (+1.24%)
OTCMKTS:BFNH

BioForce Nanosciences (BFNH) Stock Price, News & Analysis

$1.74
-0.01 (-0.57%)
(As of 04/18/2024 ET)
Today's Range
$1.41
$1.74
50-Day Range
$1.57
$2.08
52-Week Range
$0.95
$2.75
Volume
367 shs
Average Volume
1,114 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BFNH stock logo

About BioForce Nanosciences Stock (OTCMKTS:BFNH)

BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online under the BioForce Eclipse brand, as well as through social media and telemarketing. BioForce Nanosciences Holdings, Inc. was incorporated in 1999 and is based in Virginia Beach, Virginia.

BFNH Stock Price History

BFNH Stock News Headlines

Uncover this 2024 Hidden Gem
Exclusive Report: Uncover a Hidden Investment Gem We’re excited to share a special report on one exceptional, publicly traded company. This company has achieved a remarkable 22+% just this year, outperforming the market and revealing the potential for significant gains.
BioForce Nanosciences Holdings, Inc. (BFNH)
BioForce Nanosciences Holdings Inc (BFNH)
BioForce Nanosciences Holdings Inc.
See More Headlines
Receive BFNH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioForce Nanosciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/01/2024
Today
4/19/2024
Next Earnings (Estimated)
5/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
N/A
Current Symbol
OTCMKTS:BFNH
Employees
3
Year Founded
N/A

Profitability

Net Income
$-470,000.00
Pretax Margin
N/A
Return on Assets
-70,870.86%

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
-1.65
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Steven Gagnon (Age 62)
    Co-Chief Executive Officer
  • Mr. John LaViolette (Age 63)
    Co-Chief Executive Officer
  • Mr. Aleksandr Shapiro (Age 64)
    President
  • Mr. Richard Kaiser (Age 58)
    CFO, Corporate Secretary, Corporate Governance Officer, Principal Accounting Officer & Director

BFNH Stock Analysis - Frequently Asked Questions

How have BFNH shares performed in 2024?

BioForce Nanosciences' stock was trading at $2.01 at the beginning of the year. Since then, BFNH stock has decreased by 13.4% and is now trading at $1.74.
View the best growth stocks for 2024 here
.

When is BioForce Nanosciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our BFNH earnings forecast
.

How were BioForce Nanosciences' earnings last quarter?

BioForce Nanosciences Holdings, Inc. (OTCMKTS:BFNH) released its earnings results on Monday, April, 1st. The company reported ($0.01) earnings per share for the quarter.

How do I buy shares of BioForce Nanosciences?

Shares of BFNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:BFNH) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners